Nanotechnology for enrichment and detection of circulating tumor cells

Nanomedicine

Volumn 10, Issue 12, 2015, Pages 1973-1990

  Bhana, Saheel ^a   Wang, Yongmei ^a   Huang, Xiaohua ^a  

^a University of Memphis   (United States)

Author keywords

circulating tumor cells; detection; enrichment; functional nanoparticles; microfluidics; nanostructured substrates; nanotechnology

Indexed keywords

CARBON NANOTUBE; FUNCTIONAL NANOPARTICLE; MAGNETIC NANOPARTICLE; NANOPARTICLE; UNCLASSIFIED DRUG; MAGNETITE NANOPARTICLE;

CANCER DIAGNOSIS; CANCER RESEARCH; CELL ENGINEERING; CIRCULATING TUMOR CELL; CIRCULATING TUMOR CELL ENRICHMENT; FLUORESCENCE; HUMAN; MAGNETIC SEPARATION; MICROFLUIDICS; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; RAMAN SPECTROMETRY; REVIEW; ANIMAL; BATCH CELL CULTURE; CELL SEPARATION; CELL TRACKING; CHEMISTRY; IMMUNOMAGNETIC SEPARATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; TUMOR EMBOLISM;

ANIMALS; BATCH CELL CULTURE TECHNIQUES; CELL SEPARATION; CELL TRACKING; HUMANS; IMMUNOMAGNETIC SEPARATION; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; NEOPLASTIC CELLS, CIRCULATING;

EID: 84936976920     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.15.32     Document Type: Review

References (138)

1. Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell 147, 275-292 (2011).
2. Liberko M, Kolostova K, Bobek V. Essentials of circulating tumor cells for clinical research and practice. Crit. Rev. Oncol. Hematol. 88, 338-356 (2013).
3. Alix-Panabières CKP. Circulating tumor cells: liquid biopsy of cancer. Clin. Chem. 59(1), 110-118 (2013).
4. Mocellin S, Hoon D, Ambrosi A, Nitti D, Rossi CR. The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-Analysis. Clin. Cancer Res. 12, 4605-4613 (2006).
5. De Bono JS, Scher HI, Montgomery RB, et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin. Cancer Res. 14(19), 6302-6309 (2008).
6. Miller MC, Doyle GV, Terstappen LWMM. Significance of circulating tumor cells detected by the CellSearch systemin patients with metastatic breast colorectal and prostate cancer. J. Oncol. 2010, 1-8 (2010).
7. Krebs MG, Sloane R, Priest L, et al. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J. Clin. Oncol. 29(12), 1556-1563 (2011).
8. Hiltermann TJN, Pore MM, van den Berg A, et al. Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor. Ann. Oncol. 23(11), 2937-2942 (2012).
9. Hartkopf AD, Wagner P, Wallwiener D, Fehm T, Rothmund R. Changing levels of circulating tumor cells in monitoring chemotherapy response in patients with metastatic breast cancer. Anticancer Res. 31(3), 979-984 (2011).
10. Miyamoto DT, Sequist LV, Lee RJ. Circulating tumour cells-monitoring treatment response in prostate cancer. Nat. Rev. Clin. Oncol. 11(7), 401-412 (2014).
11. Smerage JB, Barlow WE, Hortobagyi GN, et al. Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500. J. Clin. Oncol. 32, 3483-3489 (2014).
12. Hüsemann Y, Geigl JB, Schubert F, et al. Systemic spread is an early step in breast cancer. Cancer Cell 13(1), 58-68 (2008).
13. Danila DC, Fleisher M, Scher HI. Circulating tumor cells as biomarkers in prostate cancer. Clin. Cancer Res. 17(12), 3903-3912 (2011).
14. den Toonder J. Circulating tumor cells: the grand challenge. Lab. Chip 11(3), 375-377 (2011).
15. Allard WJ, Matera J, Miller MC, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin. Cancer Res. 10(20), 6897-6904 (2004).
16. Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133(4), 704-715 (2008).
17. Ashworth TR. A case of cancer in which cells similar to those in the tumors were seen in the blood after death. Aust. Med. J. 14, 146-147 (1869).
18. Arya SK, Lim B, Rahman ARA. Enrichment, detection and clinical significance of circulating tumor cells. Lab. Chip 13(11), 1995-2027 (2013).
19. Aguilar ZP (Ed.). Nanomaterials For Medical Applications. Elsevier, 544 (2012).
20. Zhang Q, Uchaker E, Candelaria SL, Cao G. Nanomaterials for energy conversion and storage. Chem. Soc. Rev. 42(7), 3127-3171 (2013).
21. Wang ZL, Zhu G, Yang Y, Wang S, Pan C. Progress in nanogenerators for portable electronics. Materials Today 15(12), 532-543 (2012).
22. Zhou B, Hermans S, Somorjai GA. Nanotechnology in Catalysis. In: Nanostructure Science and Technology (Volume 3). Lockwood DJ (Ed.) Springer Science and Businees Media, LLC, NY, USA, p333 (2007).
23. Jain PK, Lee KS, El-Sayed IH, El-Sayed MA. Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine. J. Phys. Chem. B. 110(14), 7238-7248 (2006).
24. Lal S, Clare SE, Halas NJ. Nanoshell-enabled photothermal cancer therapy: impending clinical impact. Acc. Chem. Res. 41(12), 1842-1851 (2008).
25. Huang X, Neretin S, El-Sayed MA. Gold nanorods: from synthesis and properties to biological and biomedical applications. Adv. Mater. 21(48), 4880-4910 (2009).
26. Chen J, Wiley B, Li ZY, et al. Gold nanocages: engineering their structure for biomedical applications. Adv. Mater. 17(18), 2255-2261 (2005).
27. Melancon MP, Lu W, Yang Z, et al. In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy. Mol. Cancer Ther. 7(6), 1730-1739 (2008).
28. Alix-Panabières C, Pantel K. Technologies for detection of circulating tumor cells: facts and vision. Lab. Chip 14(1), 57-62 (2014).
29. Kodama RH. Magnetic nanoparticles. J. Magn. Magn. Mater. 200(1-3), 359-372 (1999).
30. Frey NA, Peng S, Cheng K, Sun S. Magnetic nanoparticles: synthesis, functionalization, and applications in bioimaging and magnetic energy storage. Chem. Soc. Rev. 38(9), 2532-2542 (2009).
31. Hoeppener AELM, Swennenhuis JF, Terstappen LWMM. Immunomagnetic separation technologies, in minimal residual disease and circulating tumor cells in breast cancer. Ignatiadis M, Sotiriou C, Pantel K (Ed.), Springer-Verlag, Berlin Heidelberg, Germany, 43-58 (2012).
32. Xu H, Aguilar ZP, Yang L, et al. Antibody conjguated magnetic iron oxide nanoparticles for cancer cell separation in fresh whole blood. Biomaterials 32, 9758-9765 (2011).
33. Pamme N. Magnetism and microfluidics. Lab. chip 6(1), 24-38 (2006).
34. Liberti PA, Rao CG, Terstappen LWMM. Optimization of ferrofluids and protocols for the enrichment of breast tumor cells in blood. J. Magn. Magn. Mater. 225(1-2), 301-307 (2001).
35. Riethdorf S, Fritsche H, Muller V, et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin. Cancer Res. 13(3), 920-928 (2007).
36. van der Auwera I, Peeters D, Benoy IH, et al. Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer. Br. J. Cancer 102(2), 276-284 (2010).
37. Lankiewicz S, Rivero BG, Böcher O. Quantitative real-Time RT-PCR of disseminated tumor cells in combination with immunomagnetic cell enrichment. Mol. Biotechnol. 34(1), 15-26 (2006).
38. Andreopoulou E, Yang LY, Rangel KM, et al. Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system. Int. J. Cancer 130(7), 1590-1597 (2012).
39. Muller V, Riethdorf S, Rack B, et al. Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study. Breast Cancer Res. 14(4), R118 (2012).
40. Miltenyi S, Muller W, Weichel W, Radbruch A. High gradient magnetic cell separation with MACS. Cytometry 11, 231-238 (1990).
41. Martin VM, Siewert C, Scharl A, et al. Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS. Exp. Hematol. 26(3), 252-264 (1998).
42. Talasaz AH, Powell AA, Huber DE, et al. Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device. Proc. Natl Acad. Sci. USA 106(10), 3970-3975 (2009).
43. Diamond E, Lee GY, Akhtar NH, et al. Isolation and characterization of circulating tumor cells in prostate cancer. Front. Oncol. 2 (131), 1-11 (2012).
44. Yang L, Lang JC, Balasubramanian P, et al. Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells. Biotechnol. Bioeng. 102(2), 521-534 (2009).
45. Lin HC, Hsu HC, Hsieh CH, et al. A negative selection system PowerMag for effective leukocyte depletion and enhanced detection of EpCAM positive and negative circulating tumor cells. Clin. Chim. Acta 419, 77-84 (2013).
46. Wu Y, Deighan CJ, Miller BL, et al. Isolation and analysis of rare cells in the blood of cancer patients using a negative depletion methodology. Method 64(2), 169-182 (2013).
47. Joshi P, Jacobs B, Derakhshan A, et al. Enrichment of circulating melanoma cells (CMCs) using negative selection from patients with metastatic melanoma. Oncotarget 5(9), 2450-2461 (2014).
48. Lara O, Tong X, Zborowski M, Chalmers JJ. Enrichment of rare cancer cells through depletion of normal cells using density and flow-Through, immunomagnetic cell separation. Exp. Hematol. 32(10), 891-904 (2004).
49. Hajba L, Guttman A. Circulating tumor-cell detection and capture using microfluidic devices. Trends Analyt. Chem. 59, 9-16 (2014).
50. Balic M, Lin H, Williams A, Datar RH, Cote RJ. Progress in circulating tumor cell capture and analysis: implications for cancer management. Expert Rev. Mol. Diagn. 12(3), 303-312 (2012).
51. Hoshino K, Chen P, Huang YY, Zhang X. Computational analysis of microfluidic immunomagnetic rare cell separation from a particulate blood flow. Anal. Chem. 84(10), 4292-4299 (2012).
52. Xia N, Hunt TP, Mayers BT, et al. Combined microfluidicmicromagnetic separation of living cells in continuous flow. Biomed. Microdevices 8(4), 299-308 (2006).
53. Adams JD, Thevoz P, Bruus H, Soh HT. Integrated acoustic and magnetic separation in microfluidic channels. Appl. Phys. Lett. 95(25), 254103 (2009).
54. Modak N, Datta A, Ganguly R. Cell separation in a microfluidic channel using magnetic microspheres. Microfluid. Nanofluidics 6, 647-660 (2009).
55. Hoshino K, Huang YY, Lane N, et al. Microchip-based immunomagnetic detection of circulating tumor cells. Lab. Chip 11(20), 3449-3457 (2011).
56. Huang Y, Hoshino K, Chen P, et al. Immunomagnetic nanoscreeing of circulating tumor cells with a motion controlled microfluidic system. Biomed. Microdevices 15(4), 673-681 (2013).
57. Wu CH, Huang YY, Chen P, et al. Versatile immunomagnetic nanocarrier platform for capturing cancer cells. ACS Nano 7(10), 8816-8823 (2013).
58. Kang JH, Krause S, Tobin H, Mammoto A, Kanapathipillai M, Ingber DE. A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells. Lab. Chip 12(12), 2175-2181 (2012).
59. Chen X, Liu J, Zhu J, Sun Y, Fan J. Optimization of microfluidic immunomagnetic chip for circulting tumor cell capture. Sensor Mater. 25(9), 667-671 (2013).
60. Yu X, He R, Li S, et al. Magneto-controllable capture and release of cancer cells by using a micropillar device decorated with graphite oxide-coated magnetic nanoparticles. Small 9(22), 3895-3901 (2013).
61. Kim S, Han SI, Park MJ, et al. Circulating tumor cell microseparator based on lateral magnetophoresis and immunomagnetic nanobeads. Anal. Chem. 85(5), 2779-2786 (2013).
62. Earharta CM, Hughes CE, Gaster RS, et al. Isolation and mutational analysis of circulating tumor cells from lung cancer patients with magnetic sifters and biochips. Lab. Chip 14(1), 78-88 (2014).
63. Wang L, Asghar W, Demirci U, Wan Y. Nanostructured substrates for isolation of circulating tumor cells. Nano Today 8, 374-387 (2013).
64. Yoon HJ, Kozminsky M, Nagrath S. Emerging role of nanomaterials in circulating tumor cell isolation and analysis. ACS Nano 8(3), 1995-2017 (2014).
65. Wang S, Wang H, Jiao J, Chen KJ, et al. Three-dimensional nanostructured substrates toward efficient capture of circulating tumor cells. Angew. Chem. Int. Ed. 48(47), 8970-8973 (2009).
66. Wang S, Liu K, Liu J, et al. Highly efficient capture of circulating tumor cells by using nanostructured silicon substrates with integrated chaotic micromixers. Angew. Chem. Int. Ed. 50(13), 3084-3088 (2011).
67. Lee SK, Kim GS, Wu Y, et al Nanowire Substrate-based Laser Scanning Cytometry for Quantitation of Circulating Tumor Cells. Nano Lett. 12(6), 2697-2704 (2012).
68. Brökera P, Lücke K, Perpeet M, Gronewold TMA. A nanostructured SAW chip-based biosensor detecting cancer cells. Sensor Actuat. B 165(1), 1-6 (2012).
69. Hou S, Zhao H, Zhao L, et al. Capture and stimulated release of circulating tumor cells on polymer-grafted silicon nanostructures. Adv. Mater. 25(11), 1547-1551 (2013).
70. Shen Q, Xu L, Zhao L, et al. Specific capture and release of circulating tumor cells using aptamer-modifi ed nanosubstrates. Adv. Mater. 25(16), 2368-2373 (2013).
71. Hong WY, Jeon SH, Lee ES, Cho Y. An integrated multifunctional platform based on biotin-doped conducting polymer nanowires for cell capture, release, and electrochemical sensing. Biomaterials 35(36), 9573-9580 (2014).
72. Zhang N, Deng Y, Tai Q, et al. Electrospun TiO2 nanofi ber-based cell capture assay for detecting circulating tumor cells from colorectal and gastric cancer patients. Adv. Mater. 24(20), 2756-2760 (2012).
73. Hou S, Zhao L, Shen Q, Yu J, et al. Polymer nanofiberembedded microchips for detection, isolation, and molecular analysis of single circulating melanoma cells. Angew. Chem. Int. Ed. 52(12), 3379-3383 (2013).
74. Yoon HJ, Kim TH, Zhang Z, et al. Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets. Nat. Nanotechnol. 8, 735-881 (2013).
75. Gu Y, Cheng J, Li Y, et al. Detection of circulating tumor cells in prostate cancer based on carboxylated graphene oxide modified light addressable potentiometric sensor. Biosens. Bioelectron. 66, 24-31 (2015).
76. Sekine J, Luo SC, Wang S, Zhu B, Tseng HR, Yu H. Functionalized conducting polymer nanodots for enhanced cell capturing: the synergistic effect of capture agents and nanostructures. Adv. Mater. 23(41), 4788-4792 (2011).
77. Han W, Allio BA, Foster DG, King MR. Nanoparticle coatings for enhanced capture of flowing cells in microtubes. ACS Nano 4(1), 174-180 (2010).
78. Sheng W, Chen T, Tan W, Fan ZH. Multivalent DNA nanospheres for enhanced capture of cancer cells in microfluidic devices. ACS Nano 7(8), 7067-7076 (2013).
79. Wan Y, Mahmood MAI, Li N, et al. Nanotextured substrates with immobilized aptamers for cancer cell isolation and cytology. Cancer 118(4), 1145-1154 (2011).
80. Chen W, Weng S, Zhang F, et al. Nanoroughened surfaces for efficient capture of circulating tumor cells without using capture antibodies. ACS Nano 7(1), 566-575 (2013).
81. Chen GD, Fachin F, Fernandez-Suarez M, Wardle BL, Toner M. Nanoporous elements in microfl uidics for multiscale manipulation of bioparticles. Small 7(8), 1061-1067 (2011).
82. Ng E, Hoshino K, Zhang X. Microfluidic immunodetection of cancer cells via site-specific microcontact printing of antibodies on nanoporous surface. Method 63(3), 266-275 (2013).
83. Mostert B, Sleijfer S, Foekens JA, Gratama JW. Circulating tumor cells (CTCs): Detection methods and their clinical relevance in breast cancer. Cancer Treat. Rev. 35(5), 463-467 (2009).
84. Yu M, Stott S, Toner M, Maheswaran S, Haber DA. Circulating tumor cells: approaches to isolation and characterization. J. Cell Biol. 192(3), 373-382 (2011).
85. Michalet X, Pinaud F, Lacoste TD, et al. Properties of fluorescent semiconductor nanocrystals and their application to biological labeling. Single Mol. 2(4), 261-276 (2001).
86. Bruchez Jr M, Moronne M, Gin P, Weiss S, Alivisatos AP. Semiconductor nanocrystals as fluorescent biological labels. Science 281(5385), 2013-2016 (1998).
87. Kairdolf BA, Smith AM, Stokes TH, Wang MD, Young AN, Nie S. Semiconductor quantum dots for bioimaging and biodiagnostic applications. Ann. Rev. Anal. Chem. 6, 143-162 (2013).
88. Hsieh YH, Liu SJ, Chen HW, Lin YK, Liang KS, Lai LJ. Highly sensitive rare cell detection based on quantum dot probe fluorescence analysis. Anal. Bioanal. Chem. 396(3), 1135-1141 (2010).
89. Hsieh YH, Lai LJ, Liu SJ, Liang KS. Rapid and sensitive detection of cancer cells by coupling with quantum dots and immunomagnetic separation at low concentrations. Biosens. Bioelectron. 26(10), 4249-4252 (2011).
90. Lee HJ, Cho HY, Oh JH, et al. Simultaneous captureand in situ analysis of circulating tumor cells using multiple hybrid nanoparticles. Biosens. Bioelectron. 47, 508-514 (2013).
91. Winnik FM, Maysinger D. Quantum dot cytotoxicity and ways to reduce it. Acc. Chem. Res. 46(3), 672-680 (2013).
92. Zhang H, Fu X, Hu J, Zhu Z. Microfluidic bead-based multienzyme-nanoparticle amplification for detection of circulating tumor cells in the blood using quantum dots labels. Anal. Chim. Acta 779, 64-71 (2013).
93. DaCosta MV, Doughan S, Han Y, Krul UJ. Lanthanide upconversion nanoparticles and applications in bioassays and bioimaging: a review. Anal. Chim. Acta 832, 1-33 (2014).
94. Fang S, Wan C, Xiang J, et al. Aptamer-conjugated upconversion nanoprobes assisted by magnetic separation for effective isolation and sensitive detection of circulating tumor cells. Nano Res. 7(9), 1327-1336 (2014).
95. Nie S, Emory SR. Probing single molecules and single nanoparticles by surface-enhanced Raman scattering. Science 275(5303), 1102-1106 (1997).
96. Kneipp K, Wang Y, Kneipp H, et al. Single molecule detection using surface-enhanced Raman scattering (SERS). Phys. Rev. Lett. 78, 1667-1670 (1997).
97. Doering WE, Piotti ME, Natan MJ, Freeman RG. SERS as a foundation for nanoscale, optically detected biological labels. Adv. Mater. 19(20), 3100-3108 (2007).
98. Sha MY, Xu H, Penn SG, Cromer R. SERS nanoparticles: a new optical detection modality for cancer diagnosis. Nanomedicine 2(5), 725-734 (2007).
99. Zavaleta CL, Smith BR, Walton I, et al. Multiplexed imaging of surface enhanced Raman scattering nanotags in living mice using noninvasive Raman spectroscopy. Proc. Natl Acad. Sci. USA 106(32), 13511-13566 (2009).
100. von Maltzahn G, Centrone A, Park JH, et al. SERS-coded gold nanorods as a multifunctional platform for densely multiplexed near-infrared imaging and photothermal heating. Adv. Mater. 21(31), 1-6 (2009).
101. Sha MY, Xu HX, Natan MJ, Cromer R. Surface-enhanced Raman scattering tags for rapid and homogeneous detection of circulating tumor cells in the presence of human whole blood. J. Am. Chem. Soc. 130(51), 17214-17215 (2008).
102. Shi W, Paproski RJ, Moore R, Zemp R. Detection of circulating tumor cells using targeted surface-enhanced Raman scattering nanoparticles and magnetic enrichment. J. Biomed. Optics 19(5), 056014 (2014).
103. Wang X, Qian XM, Beitler JJ, et al. Detection of circulating tumor cells in human peripheral blood using surfaceenhanced Raman scattering nanoparticles. Cancer Res. 71(5), 1526-1532 (2011).
104. Zhang P, Zhang R, Gao M, Zhang X. Novel nitrocellulose membrane substrate for efficient analysis of circulating tumor cells coupled with surface-enhanced Raman scattering imaging. ACS Appl. Mater. Interfaces 6(1), 370-376 (2014).
105. Nima ZA, Mahmood M, Xu Y, et al. Circulating tumor cell identification by functionalized silver-gold nanorods with multicolor, super-enhanced SERS and photothermal resonances. Sci. Rep. 4, 4752/1-8 (2014).
106. Issadore D, Chung J, Shao H, et al. Ultrasensitive clinical enumeration of rare cells ex vivo using a micro-hall detector. Sci. Transl. Med. 4(141), 141ra92/1-10 (2012).
107. Ghazani AA, Pectasides M, Sharma A, et al. Molecular characterization of scant lung tumor cells using iron-oxide nanoparticles and micro-nuclear magnetic resonance. Nanomed: Nanotechnol. Biol. Med. 10(3), 661-668 (2014).
108. Lee H, Yoon TJ, Figueiredo JL, Swirski FK, Weissleder R. Rapid detection and profiling of cancer cells in fine-needle aspirates. Proc. Natl Acad. Sci. USA 106(30), 12459-12464 (2009).
109. Bernholc J, Brenner D, Nardelli MB, Meunier V, Roland C. Mechanical and electric properties of nanotubes. Annu. Rev. Mater. Res. 32, 347-375 (2002).
110. Liu Y, Zhu F, Dan W, Fu Y, Liu S. Construction of carbon nanotube based nanoarchitectures for selective impedimetric detection of cancer cells in whole blood. Analyst 139, 5086-5092 (2014).
111. Kwon T, Park J, Lee G, et al. Carbon nanotube-patterned surface-based recognition of carcinoembryonic antigens in tumor cells for cancer diagnosis. J. Phys. Chem. Lett. 4(7), 1126-1130 (2013).
112. Maeda Y, Yoshino T, Matsunaga T. Novel nanocomposites consisting of in vivo-biotinylated bacterial magnetic particles and quantum dots for magnetic separation and fluorescent labeling of cancer cells. J. Mater. Chem. 19, 6361-6366 (2009).
113. Mi Y, Li K, Liu Y, Pu KY, Liu B, Feng SS. Herceptin functionalized polyhedral oligomeric silsesquioxaneconjugated oligomers-silica/iron oxide nanoparticles for tumor cell sorting and detection. Biomaterials 32(32), 8226-8233 (2011).
114. Kim JH, Chung HH, Jeong MS, Song MR, Kang KW, Kim JS. One-step detection of circulating tumor cells in ovarian cancer using enhanced fluorescent silica nanoparticles. Int. J. Nanomed. 8, 2247-2257 (2013).
115. Fan Z, Shelton M, Singh AK, Senapati D, Khan SA, Ray PC. Multifunctional plasmonic shell magnetic core nanoparticles for targeted diagnostics, isolation, and photothermal destruction of tumor cells. ACS Nano 6(2), 1065-1073 (2012).
116. Bhana S, Chaffin E, Wang Y, Mishra SR, Huang X. Capture and detection of cancer cells in whole blood with magnetic-optical nanoovals. Nanomedicine 9(5), 593-606 (2014).
117. Bhana S, Rai BK, Mishra SR, Wang Y, Huang X. Synthesis and properties of near infrared-Absorbing magnetic-optical nanopins. Nanoscale 4(16), 4939-4942 (2012).
118. Galanzha EI, Zharov VP. Circulating tumor cell detection and capture by photoacoustic flow cytometry in vivo and ex vivo. Cancer 5(4), 1691-1738 (2013).
119. Georgakoudi I, Solban N, Novak J, et al. In vivo flow cytometry: a new method for enumerating circulating cancer cells. Cancer Res. 64(15), 5044-5047 (2004).
120. He W, Wang H, Hartmann LC, Cheng JX, Low PS. In vivo quantification of rare circulating tumor cells by multiphoton intravital flow cytometry. Proc. Natl Acad. Sci. USA 104(28), 11760-11765 (2007).
121. Boutrus S, Greiner C, Hwu D, et al. Portable two-color in vivo flow cytometer for real-Time detection of fluorescentlylabeled circulating cells. J. Biomed. Opt. 12(2), 020507 (2007).
122. Tkaczyk ER, Zhong CF, Ye JY, et al. In vivo monitoring of multiple circulating cell populations using two-photon flow cytometry. Opt. Commun. 281, 888-894 (2008).
123. Tkaczyk ER, Tkaczyk AH, Katnik S, et al. Extended cavity laser enhanced two-photon flow cytometry. J. Biomed. Opt. 13(4), 041319/1-12 (2008).
124. Chang YC, Ye JY, Thomas TP, Cao ZY, et al. Fiber-optic multiphoton flow cytometry in whole blood and in vivo. J. Biomed. Opt. 15(4), 047004/1-9 (2010).
125. Hristozova T, Konschak R, Budach V, Tinhofer I. A simple multicolor flow cytometry protocol for detection and molecular characterization of circulating tumor cells in epithelial cancers. Cytometry A 81A, 489-495 (2012).
126. Nedosekin DA, Verkhusha VV, Melerzanov AV, Zharov VP, Galanzha EI. In vivo photoswitchable flow cytometry for direct tracking of single circulating tumor cells. Chem. Biol. 21(6), 792-801 (2014).
127. Zharov V, Galanzha E, Shashkov E, Khlebtsov N, Tuchin V. In vivo photoacoustic flow cytometry for monitoring circulating singe cancer cells and contrast agents. Opt. Lett. 31(24), 3623-3625 (2006).
128. Holan SH, Viator JA. Automated wavelet denoising of photoacoustic signals for circulating melanoma cell detection and burn image reconstruction. Phys. Med. Biol. 53(12), N227-N236 (2008).
129. Galanzha EI, Shashkov EV, Spring PM, Suen JY, Zharov VP. In vivo, noninvasive, label-free detection and eradication of circulating metastatic melanoma cells using two-color photoacoustic flow cytometry with a diode laser. Cancer Res. 69(20), 7926-7934 (2009).
130. Galanzha EI, Shashkov EV, Kelly T, Kim JW, Yang L, Zharov VP. In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumour cells. Nat. Nanotechnol. 4, 855-860 (2009).
131. Galanzha EI, Kim JM, Zharov VP. Nanotechnology-based molecular photoacoustic and photothermal flow cytometry platform for in-vivo detection and killing of circulating cancer stem cells. J. Biophoton. 2(12), 725-735 (2009).
132. Zharov VP. Ultrasharp nonlinear photothermal and photoacoustic resonances and holes beyond the spectral limit. Nat. Photon. 5, 110-116 (2011).
133. Nedosekin DA, Juratli MA, Sarimollaoglu M, et al. Photoacoustic and photothermal detection of circulating tumor cells, bacteria and nanoparticles in cerebrospinal fluid in vivo and ex vivo. J. Biophoton. 6(6-7), 523-533 (2013).
134. Galanzha E, Nedosekin DA, Sarimollaoglu M, et al. Photoacoustic and photothermal cytometry using photoswitchable proteins and nanoparticles with ultrasharp resonances. J. Biophoton. 8(1-2), 81-93 (2015).
135. Juratli M, Sarimollaoglu M, Siegel E, et al. Real-Time monitoring of circulating tumor cell release during tumor manipulation using in vivo photoacoustic and fluorescent flow cytometry. Head Neck 36(8), 1207-1215 (2014).
136. Nedosekin DA, Sarimollaoglu M, Galanzha EI, et al. Synergy of photoacoustic and fluorescence flow cytometry of circulating cells with negative and positive contrasts. J. Biophoton. 6, 425-434 (2013).
137. Zharov VP, Galanzha EI, Tuchin VV. Photothermal image flow cytometry in vivo. Opt. Lett. 30(6), 628-630 (2005).
138. Galanzha EI, Zharov VP. Photoacoustic flow cytometry. Method 57, 280-296 (2012).